New population-level data reveal unprecedented declines in cervical cancer among vaccinated cohorts, even as vaccination rates begin to slip in some countries.
A €45m expansion enables a seamless, single-site pathway from early protein discovery through CMC development to Phase 1/2 GMP manufacturing for complex biologics.
Phase 3 trial results for neurological drugs, an AI platform for central nervous system drug discovery, a novel long-acting flu antiviral, and more led the news this week.
OrganaBio launches time-sensitive PBMC isolation in San Diego, extending rapid clinical sample processing to one of the largest cell and gene therapy hubs in the country.
Dehydrodolichyl diphosphate synthase (DHDSS)-related disease has no available treatments. The new work could finally change that with nicotinamide mononucleotide (NMN).
Sessions spanning chemoproteomics, AI-driven proteomics, biotherapeutic characterization, single-cell omics, and spatial multiomics all pointed toward mass spectrometry’s growing role in drug discovery and development.
Explore key considerations for improving molecular biology workflows through centralized design, data management, and collaborative research practices.